Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK Academic Article uri icon

Overview

MeSH Major

  • Antidepressive Agents
  • Diabetic Neuropathies
  • Quality-Adjusted Life Years
  • Thiophenes

abstract

  • This UK-based economic model suggests that second-line use of duloxetine is a beneficial and cost-effective treatment strategy for diabetic peripheral neuropathic pain.

publication date

  • February 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1185/030079908X253852

PubMed ID

  • 18157921

Additional Document Info

start page

  • 385

end page

  • 99

volume

  • 24

number

  • 2